Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Melvin Sharoky Insider Profile

4 Followers

Melvin Sharoky, Director at Insmed, holds 267.90K shares in Insmed (Ticker: INSM), holds ― shares in Par Pharmaceutical Cos. Inc. (Ticker: PRX). Most recently, Melvin Sharoky Sold ― shares of Insmed on Aug 19, 2026 for an estimated value of $637.65K.

Melvin Sharoky's Trading History

INSMInsmed		Aug 19, 2026DirectorInformative Sell637.65K$30.16M
PRXPar Pharmaceutical Cos. Inc.		Apr 16, 2010―Informative Sell549.28K―
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Melvin Sharoky insider profile FAQ

What is the percentage of profitable transactions made by Melvin Sharoky?
The percentage of profitable transactions made by Melvin Sharoky is 93%.
What is the average return per transaction made by Melvin Sharoky?
The average return per transaction made by Melvin Sharoky is 25.30%.
What stocks does Melvin Sharoky hold?
Melvin Sharoky holds: INSM, PRX stocks.
What was Melvin Sharoky’s latest transaction?
Melvin Sharoky’s latest transaction was an Informative Sell of $637.65K.
What was Melvin Sharoky's most profitable transaction?
Melvin Sharoky’s most profitable transaction was an Informative Buy of INSM stock on August 14, 2014. The return on the trade was 91.10%.
What is Melvin Sharoky's role in Insmed?
Melvin Sharoky's role in Insmed is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.